MEREDITH KENDELL-DUNLOW: Open Payments
NPI 1588968978 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,372 in 67 payments from 16 companies in 2025. Trend: 2023 $547 · 2024 $1,472 · 2025 $1,372
Food & beverage: $1,372
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $315 |
| Otsuka America Pharmaceutical, Inc. | 10 | $213 |
| ABBVIE INC. | 7 | $144 |
| Alkermes, Inc. | 6 | $135 |
| Teva Pharmaceuticals USA, Inc. | 5 | $110 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Neurocrine BioSciences, Inc. | 3 | $69 |
| Tris Pharma Inc | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Almatica Pharma LLC | 2 | $41 |
Products named: CAPLYTA, REXULTI, VRAYLAR, ARISTADA, Auvelity, INGREZZA, AUSTEDO XR, Dyanavel XR.
Industry payments across KY — which companies pay providers there.
